Abstract
Background
Knowledge concerning exposure to abuse in adulthood and in pregnancy in people with multiple sclerosis (MS) is sparse.
Objective
To determine the occurrence of adult abuse and abuse in relation to pregnancy in women with MS and their risk of revictimization (repeated abuse as adults after childhood abuse).
Methods
This cross-sectional study comprised pregnant women from the Norwegian Mother, Father and Child Cohort study. Information on abuse was acquired through self-completed questionnaires. We used logistic regression to estimate adjusted odds ratios (aORs) with 95% confidence intervals (CIs).
Results
We identified 106 women with MS at enrollment through linkage with national health registries. The reference group consisted of 77,278 women without MS. Twenty-seven women (26%) with MS reported any adult abuse compared to 15,491 women (20%) without MS, aOR 1.33 (0.85–2.09). Twenty-two (21%) women with MS reported systematic emotional abuse compared to 13% without MS, aOR 1.75 (1.08–2.83). Ten women (10%) with MS reported sexual abuse, compared to 6% without MS, aOR 1.72 (0.89–3.33). More women with MS reported rape as an adult, aOR 2.37 (1.02–5.49). Women with MS had higher risk of revictimization as adults, after childhood abuse, aOR 2.23 (1.22–4.10). The risk of abuse during pregnancy or 6 months preceding pregnancy was similar between the groups.
Conclusions
Women with MS had increased occurrence of systematic emotional abuse, rape, and revictimization as adults, compared to women without MS.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
People with multiple sclerosis (MS) are more often exposed to abuse and neglect in childhood than the general population [1,2,3,4]. Mistreatment in childhood is a strong predictor of abuse later in life, known as revictimization [5]. It is not known whether abuse occurs more frequently in adulthood or during pregnancy for people with MS. However, people with physical impairment or activity limitations are at increased risk of experiencing any forms of sexual, physical, or emotional mistreatment [6, 7], including partner violence [8].
A US study found that 55% of people with advanced MS reported maltreatment by unpaid caregivers [9], most frequently emotional abuse. A focus group study found that people with advanced MS were reluctant to report being abused even though the caregiver admitted mistreatment [10]. No previous study has examined the occurrence of abuse in adulthood or the relationship to the abuser in general MS populations. Moreover, no study has examined the risk of experiencing abuse during pregnancy in women with MS.
Experiencing abuse has long-term consequences for mental and physical health [11]. Women who have previously experienced abuse may be more vulnerable for abuse during pregnancy [12]. Abuse during pregnancy is of particular concern due to the increased risk of adverse maternal and neonatal outcomes [13]. We have previously found that a history of physical or sexual abuse was a risk factor for perinatal depression in women with MS [14]. There is a need for increased attention to this issue to protect people with MS at risk and to support and provide trauma-informed care [15] for those in need.
Our aim was to investigate the occurrence of abuse in adulthood in pregnant women with MS and their risk of experiencing revictimization after childhood abuse. Further, we aimed to study their relationship to the abuser.
Materials and methods
Study design and data collection
We conducted a cross-sectional analysis based on questionnaire data from all women participating in the Norwegian Mother, Father, and Child Cohort Study (MoBa). MoBa is a nationwide, prospective cohort study, which included Norwegian-speaking pregnant women from all over Norway between 1999 and 2008 [16]. There were no exclusion criteria, and 41% of the invited women consented to participation. The MoBa cohort is linked to The Medical Birth Registry of Norway (MBRN), a nationwide medical registry containing information about all births in Norway. Registration of information in the MBRN is mandatory and performed by health personnel.
We acquired information on demographic and socioeconomic factors, medical history, and any experience of abuse from questionnaires self-administered during pregnancy weeks 17–20 and 30.
Our study is based on version 12 of the MoBa data files, covering 114,629 pregnancies. We included women who completed both the questionnaire in pregnancy week 18 and week 30, including the abuse items. To include only one observation per woman, we excluded duplicate questionnaires due to twin and triplet pregnancies and additional questionnaires from women with recurrent participations in MoBa (Fig. 1). We also excluded women who were under age 18 years at inclusion.
Flowchart of included and excluded study participants. MoBa The Norwegian Mother, Father and Child cohort study, MS multiple sclerosis, Q Questionnaire. aPregnancy week 17–20 (Q1). bWomen who completed the abuse questions in either week 17–20 (Q1) or week 30 (Q3) were included in our study. cWomen who developed MS after inclusion in MoBa until December 31, 2018 (date of data linkage) were excluded from the reference group
MS diagnosis
To validate the self-reported MS diagnosis from the questionnaires, we cross-linked the MoBa cohort with the Norwegian Patient Registry (NPR) and the Norwegian Multiple Sclerosis Registry and Biobank (The MS Registry). We also included information from hospital records. After every consultation in specialist care, registration of all relevant diagnoses in NPR is mandatory for health practitioners. The MS diagnosis in NPR has a sensitivity of 97% and a positive predictive value of 0.92 [17]. We considered the MS diagnosis as validated if registered both in the NPR and in the MS registry. The MS registry had 69% national coverage at the time of data linkage [18]. If an MS diagnosis was registered only in NPR but not in the MS registry, we reviewed hospital records to validate the diagnosis using the 2017 diagnostic criteria for MS [19]. The linkage made it possible to identify women with MS who failed to report a history of MS at inclusion in MoBa (n = 4). We were also able to refute incorrect MS diagnoses from the NPR based on the information from the hospital records. NPR-identified MS cases not included in the MS registry and without access to the hospital records for validation were excluded (Fig. 1). This data linkage also identified women who developed MS after inclusion in MoBa up until December 31, 2018 (date of data linkage). These women were excluded from the main analyses but included in a sensitivity analysis.
Abuse experience
Abuse categories
In pregnancy week 30, the women answered four questions concerning experiences of abuse (Questionnaire S1); emotional abuse—humiliation (“Has anyone over a long period of time systematically tried to subdue, degrade or humiliate you?”), emotional abuse—threat (“Has anyone threatened to hurt you or someone close to you?”), physical abuse (“Have you been subjected to physical abuse?”), and sexual abuse (“Have you been forced to do sexual actions?”). The question regarding humiliation was considered as systematic emotional abuse. The abuse questions in MoBa have been adapted from the NorVold Abuse Questionnaire showing good validity and reliability [20].
An experience of either emotional, sexual, or physical abuse as an adult was defined as responding “yes, as an adult > 18 years” to the respective categories.
Type and severity of sexual abuse in were assessed in the questionnaire in weeks 17–20; “Have you ever been pressured or forced to have sexual intercourse during this pregnancy, the last 6 months before pregnancy, or earlier?” The response options were “yes, pressured”, “yes, forced with violence” and “yes, raped.” We merged “forced with violence” and “rape” into one category of rape. This question did not distinguish between childhood and adulthood. We considered an experience of rape > 18 years of age if the woman also had reported sexual abuse as an adult in the questionnaire in week 30. Women who answered “no, never” were categorized as not having experienced rape.
Childhood abuse and revictimization
An experience of childhood abuse was defined as responding “yes, as a child < 18 years” to any of the abuse categories in the questionnaire in week 30. Women were defined as revictimized if they reported either emotional, sexual, or physical abuse both as a child (< 18 years) and as an adult (> 18 years).
Perpetrator
The questionnaire in week 30 included a question regarding the person responsible of abuse; “Who was responsible for this?”. The options were: “A stranger”, “Family or relative”, or “Another known person”.
Abuse during pregnancy or in the 6 months preceding pregnancy
The questionnaire in weeks 17–20 included two questions regarding whether the woman had experienced physical or sexual abuse during the current pregnancy or the last 6 months before pregnancy. These questions have been modified from the Abuse Assessment Screen, developed to detect abuse among pregnant women [21]. The women could also state in the week 30 questionnaire if the abuse had happened during the last 12 months. As the women were 7 months pregnant at this assessment, this comprised abuse during pregnancy and up to 5 months before pregnancy. Women who answered “yes” to either of these questions were defined as having experienced abuse during the current pregnancy or in the last 6 months before pregnancy.
Covariables
MS-specific covariables were obtained from the MS registry and hospital records: Age at MS onset (defined as first clinical symptom), age at MS diagnosis, and subtype of MS (relapsing–remitting, primary progressive, or unspecified). Other covariables were acquired through the self-completed MoBa questionnaires or through linkage to the MBRN: age, smoking (ever/never), body mass index (BMI) prior to pregnancy (< 25/ ≥ 25 kg/m2), alcohol use ≥ 1 occasion per month during the first trimester or substance use (cannabis, amphetamine, ecstasy, cocaine, heroin) the last month before or during pregnancy. Adverse socioeconomic status in adulthood was defined as either having low household income (< 60% of the study population median income in the year of participation), being a non-cohabiting mother, or having low level of education (≤ 9 years of school). Low education level of the partner was defined as ≤ 9 years of school. Depression during pregnancy was measured by a validated short version of the Hopkins Symptom Checklist 25 [22], included in the same questionnaire as the abuse questions.
Statistical analysis
The MS group was compared to a reference group of all women in MoBa without MS. We analyzed the risk for experiencing abuse by logistic regression with estimated odds ratios (ORs) and 95% confidence intervals (CIs). We considered age, history of smoking, overweight, and socioeconomic status (≥ 1 of the following: non-cohabiting mother, low level of education, low household income) as possible confounders and adjusted all models for these covariables. Low education of the woman’s partner was adjusted for in a secondary analysis when considering the person responsible of abuse, as this variable could potentially be a mediator for the association between MS and abuse. Depression was regarded as a collider and therefore not adjusted for [23]. Estimates with CIs not including 1 were considered statistically significant. Categorical variables were compared with the Pearson Chi-square test or Fisher exact test if any table cell count was expected to be < 5. Continuous variables were compared with t tests. We performed interaction analyses with logistic regression models by including interaction terms between the exposure (MS) and (1) low socioeconomic status and (2) childhood abuse on the outcome (adult abuse), adjusted for potential confounders. This was done to investigate whether women with MS were more susceptible to abuse as adults if they had low socioeconomic status or had experienced abuse in childhood. Statistical analyses were performed using IBM SPSS Statistics version 26 and Stata version 17 (StataCorp LLC).
Sensitivity analysis
As the questionnaires did not specify the exact period for the abuse experience, we lacked data on the timing of adult abuse with respect to the date of MS diagnosis. We therefore performed a sensitivity analysis comparing abuse risk in women with established MS to women who developed MS after inclusion in MoBa. The aim was to explore the direction of the associations. As women with future MS did not have the vulnerability of having a chronic condition [6, 8], higher rates of abuse in this group could signify that adult abuse predating the diagnosis could be risk or trigger factor for MS [24, 25], or associated with unknown confounders, rather than being a consequence of MS. In this analysis, we excluded women who had their first symptom of MS within 5 years after MoBa inclusion and could have been in a prodromal phase of MS [26].
Results
We identified 106 eligible women with MS and 77,278 women without MS in the cohort at baseline. Women with MS tended to be more depressed, overweight, and with a history of smoking at study baseline, and they more often had a partner with low level of education (Table 1).
Twenty-seven women (26%) with MS reported any category of adult abuse compared to 15,491 women (20%) without MS, adjusted OR (aOR) 1.33 (0.85–2.09) (Table 2). The interaction term between MS and adverse socioeconomic status on the risk of any adult abuse yielded a p value of 0.041.
Twenty-two women (21%) with MS reported systematic emotional abuse in the form of humiliation compared to 9778 women (13%) without MS, aOR 1.75 (1.08–2.83). Ten women (10%) with MS reported sexual abuse, compared to 4280 women (6%) without MS, aOR 1.72 (0.89–3.33). Women with MS more often reported to have been raped as an adult (6% vs. 3%), aOR 2.37 (1.02–5.49). The risk of physical or emotional abuse in the form of threats was not increased. Nine women (8%) with MS reported that the abuse had happened during pregnancy or in the 6-month period before pregnancy, compared to 5006 (6%) women without MS, aOR 1.44 (0.72–2.86).
Twenty-two women (21%) with MS had experienced childhood abuse, compared to 14,164 women (19%) without MS, aOR 1.24 (0.77–2.0). Women with MS had a higher risk of experiencing revictimization as adults (abuse both in childhood and adulthood), aOR 2.23 (1.22–4.10) (Table 2). Interaction analysis indicated a synergistic effect between MS and a history of childhood abuse on the risk of experiencing adult abuse (p = 0.054).
For all categories of abuse, the most common abuser was “another known person” for both women with and without MS (Table S1). For emotional abuse, 7 women with MS (27%) reported a family member or relative as responsible compared to 2474 women (19%) without MS. Very few women (n < 3) with MS reported a stranger as the abuser. The risk of emotional abuse attenuated when adjusting for partner education in addition to the potential confounders, aOR 1.39 (0.86–2.26). The risk of sexual abuse was slightly increased, aOR 1.84 (0.95–3.58), after this additional adjustment. The risk of physical abuse remained unchanged.
Sensitivity analysis
We found an increased risk of emotional abuse for women with MS when comparing them to women who developed MS in the future (≥ 5 years after study inclusion), aOR 2.79 (1.24–6.25) (Table S2). The aOR was 2.37 (0.76–7.46) for sexual abuse and 0.72 (0.15–3.55) for physical abuse.
Discussion
Our study found an increased risk of emotional abuse as well as rape in adulthood in women with MS. For emotional abuse, the risk was highest for systematic humiliation. Furthermore, women with MS had a higher occurrence of revictimization compared to women without MS.
Our population-based study extends previous knowledge on abuse in women with MS. A previous cross-sectional study examined abuse by caregivers and found that this occurred in 55% of 206 people with MS who needed assistance or care from family or friends; this compared to 26% in our population. The previous study selected MS patients with advanced disease and had a response rate of only 17%. Thus, their prevalence estimates are not directly comparable.
We found an increased risk of revictimization in women with MS. The interaction analysis indicated that having experienced abuse in childhood may increase the risk of abuse in adulthood to a larger extent in women with MS than in women without MS. Childhood abuse is a known risk factor for abuse as adults in the general population [5]. Factors associated with an increased risk of revictimization are exposure to multiple forms of childhood abuse [5, 27] and feeling shame [28].
Women with MS most often reported “another known person” as responsible for all the types of adult abuse. When adjusting the estimates for low partner education, the risk of emotional abuse decreased. In contrast, the risk of sexual abuse increased. This may indicate an association between emotional abuse and a low education in the current partner, but not so for sexual abuse. Emotional abuse was the most common abuse category in our study, similar to the previous study on caregiver abuse [9]. Sexual abuse was the least reported type of abuse by the caregivers [9]. Caregivers of people with MS often experience high levels of stress [29]. Low level of education increased the risk for fatigue and mental health problems in caregivers of MS patients [30]. Caregiver mental health problems increased the risk for caregiver abuse in people with advanced MS [9]. Increased focus on information, support, and the healthcare needs of caregivers could therefore potentially reduce the abuse risk of women with MS.
We found an interactive effect between MS and an adverse socioeconomic status the risk of abuse, meaning that women with MS and adverse socioeconomic status were more susceptible to abuse compared to women without MS who had the same socioeconomic status. Other risk factors for abuse among adults with disabilities are depression, anxiety, and impaired cognition [7, 31,32,33]. Neurologists should be aware of these associations, as these symptoms occur with increased frequency in MS [34,35,36].
The risk of abuse in the months preceding or during pregnancy was not increased in women with MS compared to women without MS. However, as many as 8% of women with MS had experienced abuse in close relation to pregnancy. Abuse during pregnancy is of particular concern because of the increased risk of physical and mental pregnancy complications [13], including perinatal depression [14].
Strengths of our study include the use of a population-based dataset with a thorough validation of the MS diagnoses. We have detailed information regarding different categories of abuse, and we adjusted for relevant confounders. Our study has some limitations. We do not know the timing of the abuse in relation to the timing of the MS diagnosis. However, we found that women with established MS had higher risk of emotional abuse compared to women who got MS more than 5 years after our assessment. This suggests that women with MS may have experienced emotional abuse because of increased vulnerability due to a manifest disease [6,7,8]. Our study has a limited sample size, which resulted in few cases in some of the abuse subcategories. Women with MS in our study were young and had short disease duration, which may limit the generalizability to what people with MS experiences during the life and disease course. We had no information on MS severity. However, we studied pregnant women with MS, who constitute a physically healthy and less disabled part of the MS population with low Expanded Disability Status Scale scores [37,38,39,40]. Therefore, physical disability should not represent a major determinant for our findings. The MoBa cohort has a participation rate of 41%, which may result in lower generalizability. However, similar response rates are considered acceptable for large prospective studies [41]. Women with Norwegian ethnicity and high socioeconomic status are overrepresented in the MoBa cohort [42], which may influence the generalizability to the whole maternal population. Nonparticipation and the underrepresentation of women with adverse socioeconomic status may underestimate the abuse prevalence but should not affect the exposure-outcome associations [41,42,43,44].
In conclusion, we found increased risk of systematic emotional abuse, rape, and revictimization in adulthood in women with MS compared to women without MS. Women with adverse socioeconomic status had a particularly increased risk. Clinicians should be aware of these associations when treating women with MS, as abuse experiences have severe and long-term impact on physical and mental health.
Data availability
Enquiries regarding access to data from MoBa and the MBRN can be directed to the Norwegian Institute of Public Health. Data from the MS Registry are accessible for researchers by application [45].
References
Spitzer C, Bouchain M, Winkler LY, Wingenfeld K, Gold SM, Grabe HJ, Barnow S, Otte C, Heesen C (2012) Childhood trauma in multiple sclerosis: a case-control study. Psychosom Med 74:312–318. https://doi.org/10.1097/PSY.0b013e31824c2013
Shaw MT, Pawlak NO, Frontario A, Sherman K, Krupp LB, Charvet LE (2017) Adverse childhood experiences are linked to age of onset and reading recognition in multiple sclerosis. Front Neurol 8:242. https://doi.org/10.3389/fneur.2017.00242
Wan A, Bernstein CN, Graff LA, Patten SB, Sareen J, Fisk JD, Bolton JM, Hitchon C, Marriott JJ, Marrie RA, Burden CTiDt, Managing the Effects of Immune-mediated Inflammatory D (2022) Childhood maltreatment and psychiatric comorbidity in immune-mediated inflammatory disorders. Psychosom Med 84:10–19. https://doi.org/10.1097/PSY.0000000000001025
Eid K, Torkildsen O, Aarseth J, Aalstad M, Bhan A, Celius EG, Cortese M, Daltveit AK, Holmoy T, Myhr KM, Riise T, Schuler S, Torkildsen CF, Wergeland S, Gilhus NE, Bjork MH (2022) Association of adverse childhood experiences with the development of multiple sclerosis. J Neurol Neurosurg Psychiatry. https://doi.org/10.1136/jnnp-2021-328700
Butler N, Quigg Z, Bellis MA (2020) Cycles of violence in England and Wales: the contribution of childhood abuse to risk of violence revictimisation in adulthood. BMC Med 18:325. https://doi.org/10.1186/s12916-020-01788-3
Plummer SB, Findley PA (2012) Women with disabilities’ experience with physical and sexual abuse: review of the literature and implications for the field. Trauma Violence Abuse 13:15–29. https://doi.org/10.1177/1524838011426014
Dammeyer J, Chapman M (2018) A national survey on violence and discrimination among people with disabilities. BMC Public Health 18:355. https://doi.org/10.1186/s12889-018-5277-0
Cohen MM, Forte T, Du Mont J, Hyman I, Romans S (2005) Intimate partner violence among Canadian women with activity limitations. J Epidemiol Community Health 59:834–839. https://doi.org/10.1136/jech.2004.022467
Morrison EH, Sorkin D, Mosqueda L, Ayutyanont N (2020) Abuse and neglect of people with multiple sclerosis: a survey with the North American Research Committee on Multiple Sclerosis (NARCOMS). Mult Scler Relat Disord 46:102530. https://doi.org/10.1016/j.msard.2020.102530
Shapiro J, Wiglesworth A, Morrison EH (2013) Views on disclosing mistreatment: a focus group study of differences between people with MS and their caregivers. Mult Scler Relat Disord 2:96–102. https://doi.org/10.1016/j.msard.2012.09.006
Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, Edwards V, Koss MP, Marks JS (1998) Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med 14:245–258. https://doi.org/10.1016/s0749-3797(98)00017-8
Taillieu TL, Brownridge DA (2010) Violence against pregnant women: prevalence, patterns, risk factors, theories, and directions for future research. Aggress Violent Beh 15:14–35. https://doi.org/10.1016/j.avb.2009.07.013
Alhusen JL, Ray E, Sharps P, Bullock L (2015) Intimate partner violence during pregnancy: maternal and neonatal outcomes. J Womens Health (Larchmt) 24:100–106. https://doi.org/10.1089/jwh.2014.4872
Eid K, Torkildsen OF, Aarseth J, Flemmen HO, Holmoy T, Lorentzen AR, Myhr KM, Riise T, Simonsen C, Torkildsen CF, Wergeland S, Willumsen JS, Oksendal N, Gilhus NE, Bjork MH (2021) Perinatal depression and anxiety in women with multiple sclerosis: a population-based cohort study. Neurology 96:e2789–e2800. https://doi.org/10.1212/WNL.0000000000012062
Raja S, Hasnain M, Hoersch M, Gove-Yin S, Rajagopalan C (2015) Trauma informed care in medicine: current knowledge and future research directions. Fam Community Health 38:216–226. https://doi.org/10.1097/FCH.0000000000000071
Magnus P, Birke C, Vejrup K, Haugan A, Alsaker E, Daltveit AK, Handal M, Haugen M, Hoiseth G, Knudsen GP, Paltiel L, Schreuder P, Tambs K, Vold L, Stoltenberg C (2016) Cohort profile update: the Norwegian mother and child cohort study (MoBa). Int J Epidemiol 45:382–388. https://doi.org/10.1093/ije/dyw029
Benjaminsen E, Myhr KM, Grytten N, Alstadhaug KB (2019) Validation of the multiple sclerosis diagnosis in the Norwegian Patient Registry. Brain Behav 9:e01422. https://doi.org/10.1002/brb3.1422
The Norwegian Directorate of Health [Helsedirektoratet]. Analysis of National Coverage: The Norwegian MS Registry and Biobank 2008–2016 [Dekningsgradsanalyse: Norsk MS-register og biobank 2008–2016] https://www.helsedirektoratet.no/tema/statistikk-registre-og-rapporter/helsedata-og-helseregistre/norsk-pasientregister-npr/innhold-og-kvalitet-i-npr/16-13323-12%20Dekningsgrad_rapport_MS_4.pdf/_/attachment/inline/851b6ae3-76d3-48e0-a297-1838565bf0e0:0c2af0b445da062adbc8c038a6d9df79c470853a/16-13323-12%20Dekningsgrad_rapport_MS_4.pdf2022
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintore M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173. https://doi.org/10.1016/S1474-4422(17)30470-2
Swahnberg IM, Wijma B (2003) The NorVold Abuse Questionnaire (NorAQ): validation of new measures of emotional, physical, and sexual abuse, and abuse in the health care system among women. Eur J Public Health 13:361–366. https://doi.org/10.1093/eurpub/13.4.361
McFarlane J, Parker B, Soeken K, Bullock L (1992) Assessing for abuse during pregnancy. Severity and frequency of injuries and associated entry into prenatal care. JAMA 267:3176–3178. https://doi.org/10.1001/jama.267.23.3176
Tambs K, Moum T (1993) How well can a few questionnaire items indicate anxiety and depression? Acta Psychiatr Scand 87:364–367
Lu H, Cole SR, Platt RW, Schisterman EF (2021) Revisiting overadjustment bias. Epidemiology 32:e22–e23. https://doi.org/10.1097/EDE.0000000000001377
Song H, Fang F, Tomasson G, Arnberg FK, Mataix-Cols D, Fernandez de la Cruz L, Almqvist C, Fall K, Valdimarsdottir UA (2018) Association of stress-related disorders with subsequent autoimmune disease. JAMA 319:2388–2400. https://doi.org/10.1001/jama.2018.7028
Jiang X, Olsson T, Hillert J, Kockum I, Alfredsson L (2020) Stressful life events are associated with the risk of multiple sclerosis. Eur J Neurol 27:2539–2548. https://doi.org/10.1111/ene.14458
Wijnands JM, Zhu F, Kingwell E, Zhao Y, Ekuma O, Lu X, Evans C, Fisk JD, Marrie RA, Tremlett H (2019) Five years before multiple sclerosis onset: phenotyping the prodrome. Mult Scler 25:1092–1101. https://doi.org/10.1177/1352458518783662
Coid J, Petruckevitch A, Feder G, Chung W, Richardson J, Moorey S (2001) Relation between childhood sexual and physical abuse and risk of revictimisation in women: a cross-sectional survey. Lancet 358:450–454. https://doi.org/10.1016/s0140-6736(01)05622-7
Aakvaag HF, Thoresen S, Wentzel-Larsen T, Dyb G (2017) Adult victimization in female survivors of childhood violence and abuse: the contribution of multiple types of violence. Violence Against Women 23:1601–1619. https://doi.org/10.1177/1077801216664427
Maguire R, Maguire P (2020) Caregiver burden in multiple sclerosis: recent trends and future directions. Curr Neurol Neurosci Rep 20:18. https://doi.org/10.1007/s11910-020-01043-5
Petrikis P, Baldouma A, Katsanos AH, Konitsiotis S, Giannopoulos S (2019) Quality of life and emotional strain in caregivers of patients with multiple sclerosis. J Clin Neurol 15:77–83. https://doi.org/10.3988/jcn.2019.15.1.77
Majeed-Ariss R, Rodriguez PM, White C (2020) The disproportionately high prevalence of learning disabilities amongst adults attending Saint Marys Sexual Assault Referral Centre. J Appl Res Intellect Disabil 33:595–603. https://doi.org/10.1111/jar.12703
Dong X, Simon M, Beck T, Evans D (2014) Decline in cognitive function and elder mistreatment: findings from the Chicago Health and Aging Project. Am J Geriatr Psychiatry 22:598–605. https://doi.org/10.1016/j.jagp.2012.11.004
Nosek MA, Hughes RB, Taylor HB, Taylor P (2006) Disability, psychosocial, and demographic characteristics of abused women with physical disabilities. Violence Against Women 12:838–850. https://doi.org/10.1177/1077801206292671
Boeschoten RE, Braamse AMJ, Beekman ATF, Cuijpers P, van Oppen P, Dekker J, Uitdehaag BMJ (2017) Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. J Neurol Sci 372:331–341. https://doi.org/10.1016/j.jns.2016.11.067
Benedict RHB, Amato MP, DeLuca J, Geurts JJG (2020) Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol 19:860–871. https://doi.org/10.1016/S1474-4422(20)30277-5
Sparaco M, Lavorgna L, Bonavita S (2021) Psychiatric disorders in multiple sclerosis. J Neurol 268:45–60. https://doi.org/10.1007/s00415-019-09426-6
Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339:285–291. https://doi.org/10.1056/NEJM199807303390501
Bsteh G, Algrang L, Hegen H, Auer M, Wurth S, Di Pauli F, Deisenhammer F, Berger T (2020) Pregnancy and multiple sclerosis in the DMT era: a cohort study in Western Austria. Mult Scler 26:69–78. https://doi.org/10.1177/1352458518816614
Alroughani R, Alowayesh MS, Ahmed SF, Behbehani R, Al-Hashel J (2018) Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era. Neurology 90:e840–e846. https://doi.org/10.1212/WNL.0000000000005065
Langer-Gould A, Gupta R, Huang S, Hagan A, Atkuri K, Leimpeter AD, Albers KB, Greenwood E, Van Den Eeden SK, Steinman L, Nelson LM (2010) Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis. Arch Neurol 67:51–57. https://doi.org/10.1001/archneurol.2009.304
Nohr EA, Frydenberg M, Henriksen TB, Olsen J (2006) Does low participation in cohort studies induce bias? Epidemiology 17:413–418. https://doi.org/10.1097/01.ede.0000220549.14177.60
Nilsen RM, Vollset SE, Gjessing HK, Skjaerven R, Melve KK, Schreuder P, Alsaker ER, Haug K, Daltveit AK, Magnus P (2009) Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol 23:597–608. https://doi.org/10.1111/j.1365-3016.2009.01062.x
Batty GD, Gale CR, Kivimaki M, Deary IJ, Bell S (2020) Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. BMJ 368:m131. https://doi.org/10.1136/bmj.m131
Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, Collins R, Allen NE (2017) Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol 186:1026–1034. https://doi.org/10.1093/aje/kwx246
Norwegian MS Registry and Biobank. Søke tilgang til data [applying for data access] [cited 2022 April 2022]. https://helse-bergen.no/norsk-ms-register-og-biobank/soke-tilgang-til-data#retningslinjer. Accessed Jan 2022
Acknowledgements
The Norwegian Mother, Father and Child Cohort study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. We acknowledge Alok Bhan MD (Department of Neurology, Stavanger University Hospital, Stavanger, Norway); Heidi Ø. Flemmen MD (Department of Neurology, Telemark Hospital Trust, Skien, Norway); Åslaug R. Lorentzen MD PhD (Department of Neurology, Sørlandet Hospital, Kristiansand, Norway); Kathrine K. Lian MD (Department of Neurology, St. Olavs Hospital, Trondheim, Norway), Stephan Schüler MD PhD (Department of Neurology, Namsos Hospital, Namsos, Norway); Cecilia S. Simonsen MD (Department of Neurology, Vestre Viken Hospital Trust, Drammen, Norway); Johannes Sverre Willumsen MD (Department of Neurology, Molde Hospital, Molde, Norway); Nina Øksendal MD (Department of Neurology, Nordland Hospital Trust, Bodø, Norway); Barbara Ratajczak-Tretel MD (Department of Neurology, Østfold Hospital, Østfold, Norway); Britt Bruland CNS (Department of Neurology, Førde Hospital, Førde, Norway) for contributing with data extraction and validation of MS diagnoses. We are grateful to all the participating families in Norway who take part in this ongoing cohort study.
Funding
Open access funding provided by University of Bergen (incl Haukeland University Hospital). K. Eid has governmental funding (doctoral scholarship) from the Western Norway Regional Health Authority [Grant number F-12503]. Neuro-SysMed is funded by the Norwegian Research Council [Grant number 288164].
Author information
Authors and Affiliations
Contributions
KE, ØFT, JA, K-MM, CFT, SW, N-EG, M-HB performed conceptualization; KE and M-HB did methodology; KE done formal analysis and investigation, writing—original draft preparation; all authors contributed to writing—review and editing; KE, M-HB were involved in funding acquisition; ØFT, NEG, M-HB supervised the study.
Corresponding author
Ethics declarations
Conflicts of interest
K. Eid has received unrestricted research grant and speaker honoraria from Novartis. Ø. Torkildsen has received speaker honoraria from and served on scientific advisory boards for Biogen, Sanofi-Aventis, Merck and Novartis. J. Aarseth has no competing interests to declare that are relevant to the content of this article. E. G. Celius has received honoraria for lecturing and advice from Biogen, Bristol Meyers Squibb, Janssen, Novartis, Merck, Roche and Sanofi, and her department has received grants from Novartis and Sanofi. M. Cortese has no competing interests to declare that are relevant to the content of this article. T. Holmøy has received speaker honoraria from Biogen, Merck, Novartis, Roche, Bristol Myers Squibb, and Sanofi and has participated in clinical trials organized by Biogen, Merck, and Roche. A. Kapali has no competing interests to declare that are relevant to the content of this article. K.M. Myhr has received unrestricted research grants to his institution; scientific advisory board and speaker honoraria from Biogen, Merck, Novartis, Roche, and Sanofi and has participated in clinical trials organized by Biogen, Merck, Novartis, Roche, and Sanofi. C.F. Torkildsen has served on scientific advisory board for Astra Zeneca. S. Wergeland has received honoraria from Biogen, Novartis, Janssen, and Sanofi. N.E. Gilhus has received honoraria from UCB, Ra, Argenx, Roche, Merck, Immunovant, Alexion. M.H. Bjørk has received personal honoraria for lecturing from Teva, Lilly, Eisai, and Novartis, consultancy honoraria from Jazz pharmaceuticals, Lundbeck and Novartis, unrestricted research support from Novartis and institutional contract research fees from Sanofi.
Ethics approval
The establishment of MoBa was based on a license from the Norwegian Data Protection Agency and approval from the Regional Committees for Medical and Health Research Ethics (REK). The MoBa cohort is regulated by the Norwegian Health Registry Act. Ethics approval for the current study was obtained from REK (reference 2016/906).
Informed consent
Written informed consent for use of information in research and for data linkage was acquired during enrollment in MoBa and the MS Registry.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Eid, K., Torkildsen, Ø., Aarseth, J. et al. Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy. J Neurol 269, 5901–5909 (2022). https://doi.org/10.1007/s00415-022-11249-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-022-11249-x